3-Bromophthalide

6940-49-4

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical ent•erprise that is market-oriented and realizes industrial develop↑ment through R&D innovation and technology transformation.

key word:

innovative Pharmaceutical

Category:

Consulting

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a laβrge health industry finance platform company integrating pharmaceutical, intelligent medical,‍ bio pharmaceutical R&D, industrial production and sales.

The chemical reactions involved in the existing pr oducts include Foucault reaction, nitration reactio→n, sulfonation reaction, hydrogenation reaction, fluorination≈ reaction, chlorination reaction, bromination reaction, diazotization reaβction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed by Mercαk. In October 2006, Sitagliptin phosphate Januvia was ♠approved by FDA as the first DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. T♦he characteristics of this drug are that it can stimulate insulin secretion whγile reducing hunger without causing weight gain. Hypoglycemia and edema wi♦ll not occur, and it is suitable for diabetic patients with poor bl≥ood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech ≥pharmaceutical enterprise that is market-oriented and realizes industrial develo‍pment through R&D innovation and technology transformati∑on.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important products for ₹the treatment of arthritis. It is well tolerated and has a low incidence of si>de effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor antagonists. In cl≈inical application, it has good therapeutic effect on atopic∞ asthma and other types of bronchial asthma, and the market prospect is huge. In the major c↕ategory of asthma drugs, leukotriene receptor antagonists have the fastest growing marke"t share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech phar™maceutical enterprise that is market-oriented and realizes industrial development through♠ R&D innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug appr♦oved by FDA for Alzheimer's disease in the United States. Its treatment reaches ♠the target dose and has low toxic and side effects. It has been widely •recognized by our medical community, and good tolerance is its biggest advantag↔e. In October 1999, Donepezil was launched in China under the trade name "Aricept",™ which is the main chemical drug against Alzheimer's disease. At present, CFDAγ has approved a number of domestic enterprises to pr÷oduce donepezil preparations, the main dosage forms are tablets, capsul≥es, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliqui☆s, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was approved for use☆ in the 27 EU member states. The world's first drug approved to prevent venous thromboemb♦olism (VTE) in adult patients undergoing elective hip or knee replacement. From June 2019 t o June 2020, the annual sales of apixaban products overse&as reached about $15.4 billion, with a year-on-year growth of nearly 32%, and the API co•nsumption reached about 23,960 kg, with a year-on-year growth of about 28%. Compared  with its main competitor, Rivaroxaban, the drug's annual overseas sales are about $4.5 bi∑llion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise tβhat is market-oriented and realizes industrial development through R&D innovation and technology≥ transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and< manufactured by Genzyme. On December 29, 2004, it was approved by FDA for the treatment of refract ory or relapsed acute lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterpri‌se that is market-oriented and realizes industrial development through R&D innovation and tecπhnology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If↕ you need other services, E-mail: 2880705932@qq.com